Literature DB >> 3026174

Human acid beta-glucosidase: Northern blot and S1 nuclease analysis of mRNA from HeLa cells and normal and Gaucher disease fibroblasts.

P N Graves, G A Grabowski, M D Ludman, P Palese, F I Smith.   

Abstract

Human acid beta-glucosidase (beta-Glc) mRNA was evaluated by dot blot, Northern blot, and S1 nuclease analyses of extracts of HeLa cells and cultured fibroblasts from normal individuals and Gaucher disease patients. Dot blot quantitation indicated an equal concentration of specific mRNA in all sources. Northern blot analyses demonstrated the presence of three poly (A)+ mRNAs of about 5,600, 2,500, and 2,000 nucleotides in length from all cell extracts. All three mRNAs were present in normal amounts in fibroblast extracts from several subtypes and variants of Gaucher disease. The largest poly (A)+ mRNA species was thought to represent an unspliced nuclear precursor for the two smaller beta-Glc mRNAs. S1 nuclease analyses, using SP6 transcripts of beta-Glc cDNA, indicated that the 2,000 nucleotide mRNA differs from the 2,500 nucleotide form at both the 5' and 3' ends. These results are consistent with the use of an alternate 5' splice site and 3' polyadenylation signal. These results also suggest that the subtype and variants of Gaucher disease result from single base alterations that lead to the synthesis of defective beta-Glc.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026174      PMCID: PMC1684132     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

Review 1.  Peptide diversity from exon choice: RNA processing regulation in the neuroendocrine system.

Authors:  S G Amara
Journal:  Mol Cell Endocrinol       Date:  1985-10       Impact factor: 4.102

2.  A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure.

Authors:  E T Schenborn; R C Mierendorf
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

3.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

4.  Role of the conserved AAUAAA sequence: four AAUAAA point mutants prevent messenger RNA 3' end formation.

Authors:  M Wickens; P Stephenson
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

5.  Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.

Authors:  P G Pentchev; B Neumeyer; L Svennerholm; C G Groth; R O Brady
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

6.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

7.  Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.

Authors:  G A Grabowski; T Dinur; K M Osiecki; J R Kruse; G Legler; S Gatt
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

8.  Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.

Authors:  G A Grabowski; J Goldblatt; T Dinur; J Kruse; L Svennerholm; S Gatt; R J Desnick
Journal:  Am J Med Genet       Date:  1985-07

9.  Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites.

Authors:  S G Amara; R M Evans; M G Rosenfeld
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

10.  Cross-reacting material in Gaucher disease fibroblasts.

Authors:  E Beutler; W Kuhl; J Sorge
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  9 in total

1.  High level transcription of the glucocerebrosidase pseudogene in normal subjects and patients with Gaucher disease.

Authors:  J Sorge; E Gross; C West; E Beutler
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease.

Authors:  E Sidransky; N Tayebi; B K Stubblefield; W Eliason; A Klineburgess; G P Pizzolato; J N Cox; J Porta; A Bottani; C D DeLozier-Blanchet
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

3.  Molecular analysis of Japanese Gaucher disease.

Authors:  T Ohashi; Y Eto
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.

Authors:  B Theophilus; T Latham; G A Grabowski; F I Smith
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

5.  Heterogeneity of mRNA expression in Italian fucosidosis patients.

Authors:  S Guazzi; P Persici; R Gatti; P Durand; J S O'Brien; G Romeo
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

6.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease.

Authors:  T Latham; G A Grabowski; B D Theophilus; F I Smith
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

7.  Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.

Authors:  J A Nolta; X J Yu; I Bahner; D B Kohn
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Posttranslational processing of human lysosomal acid beta-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts.

Authors:  J E Bergmann; G A Grabowski
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

9.  Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene.

Authors:  N Dahl; M Lagerström; A Erikson; U Pettersson
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.